Thomas Seck, MD, from Boehringer Ingelheim, spoke with us about the results of the landmark EMPA-REG OUTCOME trial and what they mean for the treatment of diabetes and cardiovascular disease.
Thomas Seck, MD, from Boehringer Ingelheim, spoke with us about the results of the landmark EMPA-REG OUTCOME trial and what they mean for the treatment of diabetes and cardiovascular disease.
Thomas Seck, MD, from Boehringer Ingelheim, spoke with us about the results of the landmark EMPA-REG OUTCOME trial and what they mean for the treatment of diabetes and cardiovascular disease.
<p>Scott Zellner, from DePuy Synthes, discusses the Anterior Approach, why its a growing trend, and why its a better surgical option for patients.</p>
<p>Scott Zellner, from DePuy Synthes, discusses the Anterior Approach, why its a growing trend, and why its a better surgical option for patients.</p>
Sharon Donovan, PhD, RD, from the University of Illinois and American Society for Nutrition, discusses new recommendations for food allergies in children.